Business description: Quoin Pharmaceuticals, Ltd.

Quoin Pharmaceuticals Ltd, former Cellect Biotechnology Ltd, is an Israel-based specialty pharmaceutical company, focused on developing and commercializing therapeutic products that treat rare and orphan diseases. The Company’s first lead product is QRX003, a once daily, topical lotion comprised of a broad-spectrum serine protease inhibitor, formulated with the proprietary Invisicare technology, to treat Netherton Syndrome. The product going to be developed for other rare dermatological diseases including Peeling Skin Syndrome, SAM Syndrome, and Palmoplantar Keratoderma. Quoin is also developing QRX004 as a potential treatment for Dystrophic Epidermolysis Bullosa, and QRX006 as a potential therapy for an, as of yet, undisclosed rare skin disease.

Number of employees: 4

Sales by Activity: Quoin Pharmaceuticals, Ltd.

Fiscal Period: December20192020202120222023
See all business segments

Managers: Quoin Pharmaceuticals, Ltd.

Insider TitleAgeSince
Founder 55 04/03/18
Chief Executive Officer 62 04/03/18
Director of Finance/CFO 60 31/10/21
See QUOIN PHARMACEUTICALS, LTD. governance

Members of the board: Quoin Pharmaceuticals, Ltd.

Insider TitleAgeSince
Chief Executive Officer 62 04/03/18
Founder 55 04/03/18
Director/Board Member 73 27/10/21
Director/Board Member 39 27/10/21
Composition of the Board of Directors

Shareholders: Quoin Pharmaceuticals, Ltd.

NameEquities%Valuation
Altium Capital Management LP
1.664 %
66,240 1.664 % 38 419 $
Renaissance Technologies LLC
1.169 %
46,513 1.169 % 26 978 $
Virtu Financial LLC
0.7726 %
30,749 0.7726 % 17 834 $
HRT Financial LLC
0.7617 %
30,314 0.7617 % 17 582 $
Citadel Securities GP LLC
0.2710 %
10,786 0.2710 % 6 256 $
NameEquities%Valuation
9,358 0.2539 % - $
9,357 0.2539 % - $
317 0.008600 % - $
Dennis Langer
0.001438 %
53 0.001438 % - $
Natalie Leong
0.000000 %
0 0.000000 % - $
List of QUOIN PHARMACEUTICALS, LTD. shareholders

Company details: Quoin Pharmaceuticals, Ltd.

Quoin Pharmaceuticals Ltd.

42127 Pleasant Forest Court

20148-7349, Ashburn

+

http://www.quoinpharma.com
address Quoin Pharmaceuticals, Ltd.(QNRX)

Other Biotechnology & Medical Research

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.99%-7.58%-92.12% - 2.4M
+3.13%+0.79%+0.34%-63.59% 45.3B
+0.08%+4.93%+1.88%-4.59% 43.52B
+7.12%+8.15%+12.82%-18.40% 42.73B
+1.89%+1.73%+24.47%+35.20% 29.91B
+2.22%+0.47%+31.21%-23.59% 28.86B
-1.76%-1.41%+29.45%+49.63% 27.43B
+2.88%+4.20%+40.01%+86.86% 14.71B
+2.73%+4.54%-7.92%-32.76% 12.23B
+1.43%-9.03%+50.30%+112.58% 11.81B
Average +1.69%-2.12%+9.04%+15.70% 25.65B
Weighted average by Cap. +2.06%-0.30%+16.26%+0.29%
See all sector performances
  1. Stock Market
  2. Equities
  3. QNRX Stock
  4. Company Quoin Pharmaceuticals, Ltd.